Cargando…
Global MYCN Transcription Factor Binding Analysis in Neuroblastoma Reveals Association with Distinct E-Box Motifs and Regions of DNA Hypermethylation
BACKGROUND: Neuroblastoma, a cancer derived from precursor cells of the sympathetic nervous system, is a major cause of childhood cancer related deaths. The single most important prognostic indicator of poor clinical outcome in this disease is genomic amplification of MYCN, a member of a family of o...
Autores principales: | Murphy, Derek M., Buckley, Patrick G., Bryan, Kenneth, Das, Sudipto, Alcock, Leah, Foley, Niamh H., Prenter, Suzanne, Bray, Isabella, Watters, Karen M., Higgins, Desmond, Stallings, Raymond L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781550/ https://www.ncbi.nlm.nih.gov/pubmed/19997598 http://dx.doi.org/10.1371/journal.pone.0008154 |
Ejemplares similares
-
Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
por: Bray, Isabella, et al.
Publicado: (2009) -
Co-Localization of the Oncogenic Transcription Factor MYCN and the DNA Methyl Binding Protein MeCP2 at Genomic Sites in Neuroblastoma
por: Murphy, Derek M., et al.
Publicado: (2011) -
Modulation of Neuroblastoma Disease Pathogenesis By An Extensive Network of Epigenetically Regulated MicroRNAs
por: Das, Sudipto, et al.
Publicado: (2012) -
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
por: Foley, Niamh H, et al.
Publicado: (2010) -
MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1
por: Creevey, Laura, et al.
Publicado: (2013)